Significant data integrity violations were found at the Zhejiang facility of NingBo Huize Commodity Co., according to a warning letter FDA sent to the company on Aug. 2, 2019. According to FDA, during the inspection, which occurred from March 18 22, 2019, the company s quality staff admittedOriginal Article
You may also like
Nouscom to present re‑treatment data in Lynch...
ViiV Healthcare to unveil new HIV treatment data at...
Almirall’s paediatric registration of Ebglyss for...
The Bloc appoints Jon Chapman as European Executive...
UCSD, IGI Partnership Expands CRISPR Innovation Across...
10x Clinical Expansion Advances with CLIA Lab Plans...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.